Back to 
Tudor Investment Corp.
Tudor Investment Corp.
CLDX
Showing 0 of 2 quarters
Position history for Tudor Investment Corp.'s holdings in Celldex Therapeutics, Inc.
As of its Q4 2018 13F, Tudor Investment held 65,439 shares of CLDX (Celldex Therapeutics), worth $13,000.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.